Figure 5.

The QSant assay can detect different clinical transplant rejection phenotypes and can detect both clinical and sub-clinical acute rejection. (A) The study composed of AR patients with antibody-mediated rejection (ABMR; n = 24) and T-cell-mediated rejection (TCMR; n = 44). No statistically significant difference was observed between two groups, which indicated that Q-Score can effectively detect both rejection phenotypes (p = 0.076). (B) The Q-Score was not significantly different between clinical rejection (n = 39) and sub-clinical rejection (n = 32) groups (p = 0.720).